查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362973

幽门螺旋桿菌感染诊断市场规模、份额和趋势分析报告：按类型、技术、最终用途、地区、细分趋势，2023-2030

Helicobacter Pylori Diagnostics Market Size, Share & Trends Analysis Report By Type (Instruments, Reagents), By Technology (Immunoassays, POC), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

幽门螺旋桿菌感染诊断市场成长与趋势：

Grand View Research的最新报告显示，到2030年，全球幽门螺旋桿菌感染诊断市场规模预计将达到7.5784亿美元。

预计在预测期内年复合成长率为 4.5%。对个体化抗生素治疗的需求不断增加，加上幽门螺旋桿菌感染诊断的成本效益不断提高，预计将推动成长。

抗生素的可用性、可负担性和治疗持续时间短预计将推动对抗生素采用以及前后监测测试的需求。此外，幽门螺旋桿菌病菌感染罹患率上升、早期诊断的需求以及诊断技术的快速进步等要素推动了市场的成长。然而，由于竞争环境，维持经济价格的压力越来越大，可能会阻碍幽门螺旋桿菌感染诊断市场的成长。

幽门螺旋桿菌是一种常见于胃中的需氧革兰氏阴性细菌。虽然有利于保持胃生态系统的平衡，但它可能会导致胃壁感染。这种细菌可以作为胃癌、十二指肠溃疡、胃炎和溃疡以及小肠感染疾病的病原体之一。因此，对幽门螺旋桿菌病菌感染诊断的需求不断增长，从而能够早期发现幽门螺旋桿菌感染。如果幽门螺旋桿菌溃疡确诊为阳性，患者将接受抗生素治疗 10 至 14 天。幽门螺旋桿菌的治疗可能包括抗生素的组合，例如甲硝唑、阿莫西林、克拉霉素和四环素，以及质子帮浦抑制剂、雷尼替丁柠檬酸铋和碱性水杨酸铋。

免疫分析技术领域在 2018 年占据最大的市场占有率，预计在预测期内年复合成长率最快。就最终用户而言，医院领域在2018年占据了最大的市场占有率，而诊断实验室预计在未来年度将以最快的年复合成长率扩张。按地区划分，北美引领幽门螺旋桿菌感染诊断的全球市场。同时，亚太地区预计 2019 年至 2026 年年复合成长率最快。

幽门螺旋桿菌感染诊断市场报告亮点

  • 免疫分析技术将在 2022 年占据最大的市场占有率，预计在预测期内复合年复合成长率最快。
  • 在最终用户中，医院细分市场预计将在 2022 年占据最大的市场占有率，而诊断实验室细分市场预计将在 2023 年至 2030 年呈现最快的年复合成长率。
  • 由于医疗领域的重要性日益增加、感染疾病的流行和意识的提高，拉丁美洲在预测期内预计将以 6.4%的年复合成长率快速增长。

目录

第1章调查方法与范围

第2章执行摘要

第3章幽门螺旋桿菌感染诊断市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 幽门螺旋桿菌感染诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章幽门螺旋桿菌感染诊断市场：类型估计和趋势分析

  • 幽门螺旋桿菌感染诊断市场：重点
  • 幽门螺旋桿菌感染诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 装置
  • 试剂
  • 服务

第5章幽门螺旋桿菌感染诊断市场：技术评估与趋势分析

  • 幽门螺旋桿菌感染诊断市场：重点
  • 幽门螺旋桿菌感染诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 免疫测定法
  • POC
  • 分子诊断

第6章幽门螺旋桿菌感染诊断：最终用户估计和趋势分析

  • 幽门螺旋桿菌感染诊断市场：重点
  • 幽门螺旋桿菌感染诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院
  • 诊断实验室
  • 诊所

第7章幽门螺旋桿菌感染诊断市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的幽门螺旋桿菌感染诊断市场：要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Thermo Fisher Scientific
    • Biohit Oyj
    • Quest Diagnostics Incorporated
    • Meridian Bioscience
    • Bio-Rad Laboratories
    • Alpha Laboratories Ltd
    • F. Hoffmann-La Roche Ltd
    • Coris BioConcept
    • Certest Biotec
    • Epitope Diagnostics, Inc.
Product Code: GVR-3-68038-699-8

Helicobacter Pylori Diagnostics Market Growth & Trends:

The global helicobacter pylori diagnostics market size is anticipated to reach USD 757.84 million by 2030, according to a new report by Grand View Research. It is expected to expand at a CAGR of 4.5% over the forecast period. Increasing demand for personalized antibiotic therapy coupled with improved cost-effectiveness Helicobacter pylori (H. pylori) infection diagnosis is projected to drive the growth.

Easy accessibility and affordability of antibiotics along with short treatment durations will boost the adoption of antibiotics as well as the demand for pre and post monitoring tests. Furthermore, factors such as rising incidence of H. pylori infections, need for early diagnosis, and rapid technological advancements in diagnostic techniques will propel the market growth. However, rising pressure of maintaining economic pricing due to the extremely competitive environment may hinder the growth of the Helicobacter pylori diagnostics market.

H. pylori is an aerobic gram-negative bacteria generally found in the stomach. Although advantageous for balancing the stomach ecology, it can cause infection to the inner stomach lining. The bacteria can act as one of the causative agents for stomach cancer, duodenal ulcers, gastritis and gastric ulcers, and infection to the small intestine, among other conditions. This has led to an increase in the demand for Helicobacter pylori diagnostics that enable early detection of H. pylori infection. Patients are subject to an antibiotic therapy for 10 to 14 days, in case of positive diagnosis of ulcers caused by this bacteria. Treatment for H. pylori could include a combination of antibiotics such as metronidazole, amoxicillin, clarithromycin, tetracycline, or with a proton pump inhibitor, ranitidine bismuth citrate, and bismuth subsalicylate.

The immunoassay technology segment held the largest market share in 2018 and is expected to register the fastest CAGR over the forecast period. In terms of end user, the hospital segment held the largest market share in 2018, while diagnostic laboratories is anticipated to expand at the fastest CAGR in the forthcoming years. In terms of region, North America led the global market for Helicobacter pylori diagnostics. Asia Pacific, on the other hand, is expected to witness the fastest CAGR from 2019 to 2026.

Helicobacter Pylori Diagnostics Market Report Highlights:

  • Immunoassays technology held the largest market share in 2022 and is expected to witness the fastest CAGR over the forecast period
  • Among end user, hospital segment held the largest market share in 2022, while the diagnostics laboratories segment is expected to demonstrate the fastest CAGR from 2023 to 2030
  • Latin America is anticipated to grow at the fastest CAGR of 6.4% in the forecast period owing to the rising importance to the healthcare sector, increasing infectious diseases prevalence, and awareness.
  • Key players operating in the Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Biohit, Meridian Bioscience, Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Quest Diagnostics, Coris BioConcept, Certest Biotec, and Epitope Diagnostics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Technology
    • 1.1.3. End-user
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End-user outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Helicobacter Pylori Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Helicobacter Pylori Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Helicobacter Pylori Diagnostics Market: Type Estimates & Trend Analysis

  • 4.1. Helicobacter Pylori Diagnostics Market: Key Takeaways
  • 4.2. Helicobacter Pylori Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Instruments
    • 4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Helicobacter Pylori Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Helicobacter Pylori Diagnostics Market: Key Takeaways
  • 5.2. Helicobacter Pylori Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Immunoassays
    • 5.3.1. Immunoassays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. POC
    • 5.4.1. POC market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Molecular Diagnostics
    • 5.5.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Helicobacter Pylori Diagnostics: End-user Estimates & Trend Analysis

  • 6.1. Helicobacter Pylori Diagnostics Market: Key Takeaways
  • 6.2. Helicobacter Pylori Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Diagnostics Laboratories
    • 6.4.1. Diagnostics laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Helicobacter Pylori Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Helicobacter Pylori Diagnostics Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Thermo Fisher Scientific
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Biohit Oyj
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Quest Diagnostics Incorporated
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Meridian Bioscience
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Bio-Rad Laboratories
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Alpha Laboratories Ltd
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. F. Hoffmann-La Roche Ltd
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Coris BioConcept
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Certest Biotec
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Epitope Diagnostics, Inc.
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Europe helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 23 France helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Sweden helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Sweden helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 35 Norway helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Norway helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Denmark helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Denmark helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Japan helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 48 China helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 49 China helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 51 India helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Australia helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Thailand helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Thailand helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 South Korea helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Latin America helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa helicobacter pylori diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Africa helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Africa helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Africa helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait helicobacter pylori diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait helicobacter pylori diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait helicobacter pylori diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Helicobacter pylori diagnostics: Market outlook
  • Fig. 9 Helicobacter pylori diagnostics competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Helicobacter pylori diagnostics market driver impact
  • Fig. 15 Helicobacter pylori diagnostics market restraint impact
  • Fig. 16 Helicobacter pylori diagnostics market strategic initiatives analysis
  • Fig. 17 Helicobacter pylori diagnostics market: Type movement analysis
  • Fig. 18 Helicobacter pylori diagnostics market: Type outlook and key takeaways
  • Fig. 19 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Helicobacter pylori diagnostics market: Technology movement analysis
  • Fig. 23 Helicobacter pylori diagnostics market: Technology outlook and key takeaways
  • Fig. 24 Immunoassays Solid market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 POC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Helicobacter pylori diagnostics market: End-use movement analysis
  • Fig. 28 Helicobacter pylori diagnostics market: End-use outlook and key takeaways
  • Fig. 29 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Diagnostics laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global helicobacter pylori diagnostics market: Regional movement analysis
  • Fig. 33 Global helicobacter pylori diagnostics market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, ((USD Million) USD Million) 2018 - 2030
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)